Article information
Objetivo
Conocer la prevalencia de candidiasis vaginal en embarazadas controladas desde atención primaria y ver si está aumentando con el paso del tiempo.
DiseñoEstudio descriptivo, retrospectivo del universo de mujeres embarazadas.
EmplazamientoZona Básica de Salud Cazoña (34.783 habitantes).
SujetosToda la población obstétrica controlada en nuestro centro de salud desde 1992 a 1997, ambos inclusive.
Mediciones y resultadosEstudio retrospectivo de las historias clínicas de todas las mujeres embarazadas captadas en nuestro centro de salud (878 embarazos). Descartados los derivados a tocólogo, abortos y partos prematuros, se han valorado 549 embarazos (62,30% del total) normales, de bajo riesgo, controlados hasta el final por atención primaria, con un rango de edad de 16-40 años. La prevalencia media de candidiasis es de un 18% (IC, 15,0-21,6). Su frecuencia aumenta a medida que se incrementa el número de gestaciones y disminuye a medida que aumenta la edad de la embarazada.
ConclusionesLa prevalencia encontrada en nuestro estudio es de un 18%, y no está aumentando a medida que pasan los años.
Palabras clave:
Vulvovaginitis
Candidiasis
Embarazo
Objectives
To find the prevalence of vaginal candidiasis in pregnant women monitored through primary care and to see whether it is on the increase.
DesignDescriptive and retrospective study of pregnant women.
SettingCazoña Health District (34783 inhabitants).
SubjectsThe entire obstetric population monitored by our health centre between 1992 and 1997 inclusive.
Measurements and resultsRetrospective study of clinical histories of all the pregnant women seen at our health centre (878 pregnancies). After discounting those referred to obstetricians, abortions/ miscarriages and premature births, 549 normal low-risk pregnancies (62.30% of the total) were monitored to completion in primary care. The women's age range was 16 to 40. The mean prevalence of candidiasis was 18% (CI, 15.0-21.6). Its frequency increased as the number of pregnancies increased and dropped as the age of the pregnant women increased.
ConclusionsPrevalence found in our study was 18% and did not increase as the years passed.
Key words:
Vulvovaginitis
Candidiasis
Pregnancy
Full text is only aviable in PDF
Bibliografía
[1.]
Academia Española de Dermatología y Sifilografía.
Epidemiología y patogenia de la candidiasis vaginal.
Micología y micosis, pp. 7-13
[2.]
J.F. García, J. Schneider, J. Pontón.
Vulvovaginitis candidiásica.
Med Clin (Barc), 103 (1994), pp. 505-508
[3.]
D.R. Blake, A. Duggan, T. Quinn, J. Zenilman, A. Joffe.
Evaluation of vaginal infection in adolescent women: can it be done without a speculum?.
Pediatrics, 102 (1998), pp. 939-944
[4.]
V. Chandeying, S. Skov, M. Kemapunmanus, M. Law, A. Greater, P. Rowe.
Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand.
Sex Transm Infect, 74 (1998), pp. 194-201
[5.]
L. Otero, V. Palacio, F. Carrero, F.S. Méndez, F. Vázquez.
Vulvovaginal candidiasis in female sex workers.
Int J Std Aids, 9 (1998), pp. 526-530
[6.]
A.M. Geiger, B. Foxman.
Risk factors for vulvovaginal candidiasis: a case control study among university students.
Epidemiology, 7 (1996), pp. 182-187
[7.]
B.F. Cosgrove, K. Reeves, D. Mullins, M.J. Ford, F.A. Ramos Caro.
Congenital cutaneous candidiasis associated with respiratory distress and elevation of liver function test: a case report and review of the literature.
J Am Acad Dermatol, 37 (1997), pp. 817-823
[8.]
O. Band, C. Boithias, T. Lacaze-Masmonteil, Y. Ville, M. Guibert, V. Zupan, et al.
Maternofetal disseminated candidiasis and high-grade prematurity (see comments).
Arch Pediatr, (1997), pp. 903
[9.]
S.M. Khambadkone, K.M. Dixit, A. Divekar, S.M. Joshi, S.F. Irani, M. Disei.
Congenital candidiasis.
Indian Pediatr, 33 (1996), pp. 512-516
[10.]
J.T. Van Winter, J.A. Ney, P.L. Ogburn Jr, R.V. Johnson.
Preterm lebon and congenital candidiasis; a case report.
J Reprod Med, 39 (1994), pp. 987-990
[11.]
H.L. Loke, I. Verber, W. Szymonowicz, V.Y. Yu.
Systemic candidiasis and pneumonia in preterm infants.
Aust Paediatr J, 24 (1998), pp. 138-142
[12.]
G. Chaland, D. Bouygues.
Congenital cutaneous candidiasis. 2 case reports.
Pediatrie, 41 (1986), pp. 321-327
[13.]
D. Gaillard, A. Lallemand, J.J. Adnet, V. Vernet.
Fetal and congenital candidiasis.
Arch Anat Cytol Pathol, 33 (1985), pp. 26-31
[14.]
C.M. Engelhart, N.M. Van de Vijver, S.J. Nienhuis, T.H. Hasaart.
Fetal candida sepsis at midgestation: a case report.
Eur J Obstet Gynecol Rep Biol, 77 (1998), pp. 107-109
[15.]
R.L. Schlosser, A. Zubcov, M. Bollinger, M. Kuhnert, V. Loewenich.
Congenital candida infections.
Monatsschr Kinderheilkd, 141 (1993), pp. 864-867
[16.]
G.G. Donders, S. Gordts, A. Cornelis, P. Moerman.
Intrauterine candidasis in a twin pregnancy after myomectomy, in vitro fertilization and embryo tranfer.
Arch Ginecolo Obstet, 259 (1997), pp. 201-204
[17.]
G. Hart.
Factors associated with trichomoniasis, candidiasis and bacterial vaginosis.
Int J STD AIDS, 4 (1993), pp. 21-25
[18.]
M.F. Cotch, S.L. Hillier, R.S. Gibss, D.A. Eschenbech.
Epidemiology and outcomes associated with moderate to heavy candida colonization during pregnancy. Vaginal infections and prematurity study group.
Am J Obstet Gynecol, 178 (1998), pp. 374-380
[19.]
A. Nichols, T.Y. Khong, C.A. Crowther.
Candida tropicalis chorioamnionitis.
Am J Obstet Gynecol, 172 (1995), pp. 1.045-1.047
[20.]
D.E. Westney, L.S. Westney, A.A. Johnson, E.M. Knight, V.J. Oyemede, O.J. Cole, et al.
Nutrition, genital tract infection, hematologyc values, and premature rupture of membranes among african american women.
J Nutr, 124 (1994), pp. 9.875-9.935
[21.]
F. Prieto-Valderrey, J.L. Teja Barbero, T. Obeso-González, A. Castellanos Ortega, J.P. Santridrian Miguel.
SDRA recurrente tras neumonía varicelosa complicada con candidiasis diseminada en mujer gestante.
An Med Intern, 13 (1996), pp. 491-493
[22.]
T.N. Moyana, A. Kulaga, J. Xiang.
Granulomatous appendicitis in acute myeloblastic leukemia: expanding the clinicopathologic spectrum of invasive candidiasis.
Arch Patol Lab Med, 120 (1996), pp. 203-205
[23.]
D.N. Burns, R. Tuomala, B.H. Chang, R. Hershow, H. Minkoff, E. Rodríguez, et al.
Vaginal colonization or infection with Candida albicans in human inmunodeficiency virus-infected women during pregnancy and during the postpartum period. Women and infants transmissions study group.
Clin Infect Dis, 24 (1997), pp. 201-210
[24.]
M. Pellicano, A. Castellano, G. Magri, R. Vigorito, E. Carnevale, D De Falco, et al.
Vulvovaginitis and reproduction.
Clin Exp Obstet Gynecol, 22 (1995), pp. 51-65
[25.]
T. Ohba, N. Nakamura, K. Matsui, M. Ito, H. Okamura.
High incidence of vaginal candidiasis in HTLV-I carrier pregnant women.
Nippon Sanka Fujinka Gakkai Zasshi, 44 (1992), pp. 742-744
[26.]
T. Nohmi, S. Abe, K. Dobeshi, S. Tansho, H. Yamaguchi.
Supression of anti-candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis.
Microbiol-Inmunol, 39 (1995), pp. 405-409
[27.]
J.D. Sobel.
Epidemilogy and pathogenesis of recurrent vulvovaginal candidiasis.
Am J Obstet-Gynecol, 152 (1985), pp. 924-935
[28.]
I. Milsom, L. Forssman.
Repeated candidiasis: reinfection or recrudescence. A review.
Am J Obstet Gynecol, 152 (1985), pp. 956-959
[29.]
D.D. Glover, B. Larsen.
Longitudinal investigation of candida vaginitis in pregnancy: role of superimposed antibiotic use.
Obstet Gynecol, 91 (1998), pp. 115-188
[30.]
C.M. Maffei, C.R. Paula, T.S. Mazzocato, S. Franceschini.
Phenotype and genotype of Candida albicans strains isolated from pregnant women with recurrent vaginitis.
Mycophatologia, 137 (1997), pp. 87-94
[31.]
A. Spinillo, G. Pizzoli, L. Colonna, S. Nicola, F. De Seta, S. Guaschino.
Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis.
Obstet Gynecol, 81 (1993), pp. 721-727
[32.]
S.E. Reef, W.C. Levine, M.N. McNeil, S. Fisher-Hoch, S.D. Holmberg, A. Duerr, et al.
Treatment options for vulvovaginal candidiasis. 1993.
Clin Infec Dis, 20 (1995), pp. 80-90
[33.]
W. Inman, G. Pearce, L. Wilton.
Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.
Eur J Clin Pharmacol, 46 (1994), pp. 115-118
[34.]
P.L. Doering, T.M. Santiago.
Drugs for treatment of vulvovaginal candidasis: comparative efficay of agents and vagimens.
DICP, 24 (1990), pp. 1.078-1.083
[35.]
L. Hagler, L. Brett.
Treatment of vaginal candidiasis in pregnant women.
Clin Ther, 9 (1987), pp. 559-561
[36.]
Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvanie.
Treatment of vaginal candidiasis in pregnant women.
Clin Ther, 8 (1986), pp. 563-567
[37.]
J.A. Pritchard.
Cuidados prenatales.
Obstetricia (3.a ed.), pp. 254
[38.]
M.F. Rein.
Enfermedades de transmisión sexual.
Medicina interna (3.a ed.), pp. 1.311
[39.]
L.O. Eckert, S.E. Hawes, C.E. Stevens, L.A. Koutsky, D.A. Eschenbech, K.K. Holmes.
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorith.
Obstet Gynecol, 92 (1998), pp. 757-765
[40.]
S. Kukner, E. Kusku, T. Ergin, O. Gokman.
Vaginal thrush and its management in pregnancy.
JPMA J Pek Med Assoc, 45 (1995), pp. 15-16
[41.]
E.E. Koumantakis, L.A. Hassan, E.K. Deligeoroglou, G.K. Creatses.
Vulvovaginitis during childhood and adolescence.
J Pediatr Adolesc Gynecol, 10 (1997), pp. 39-43
[42.]
D.S. Heller, P. Randolph, A. Young, M.L. Tancer, D. Fromer.
The cutaneous-vulvar clinic revisited: a five year experience of the Columbia Presbyterian Medical Center Cutaneous-vulvar service.
Dermatology, 195 (1997), pp. 26-29
[43.]
A.M. Geiger, B. Foxmen, B.W. Gillespie.
The epidemiology of vulvovaginal candidiasis among university students.
Am J Public Health, 85 (1995), pp. 1.146-1.148
[44.]
J. Emmerson, A. Gumputrao, J. Hawkswell, A. Dexter, R. Sykes, S. Searle, et al.
Sampling for vaginal candidiasis: how good is it?.
Int J Std Aids, 5 (1994), pp. 356-358
[45.]
M. Ceruti, M. Canestrelli, G. Pientelli, F. Amone, V. Condemi, P De Paolis, et al.
Vaginitis and vaginosis. Comparasion of two periods.
Minerva Ginecol, 45 (1993), pp. 479-483
[46.]
K.H. Abu-Elteen, A.M. Abdul Malek, N.A. Abdul Wahid.
Prevalence and susceptibility of vaginal yeast isolates in Jordan.
Mycoses, 40 (1997), pp. 179-185
[47.]
D.M. Gertig, S.H. Kapiga, J.F. Shao, D.J. Hunter.
Risk factors for sexually transmitted diseases among women attending family planing clinics in Dar-es-Salam, Tanzania.
Genitourin Med, 73 (1997), pp. 39-43
[48.]
J.M. De Oliveira, A.S. Cruz, A.F. Fonseca, E.P. Ves, A. Rodríguez, F. Aurea, et al.
Prevalence of Candida albicans in vaginal fluid of asymptomatic portuguese women.
J Rep Med, 38 (1993), pp. 41-42
[49.]
Y.H. Faye-Katte, A.A. Konassi, D.F. Sylla-Koko, A.A. Kacon-N'-Douba, G. Akona-Koffi, Y.B. Acho, et al.
Prevalence of four agents of sexually transmitted diseases in leukorrhea in Abidjan (Ivory Coast).
Bull Soc Pathol Exot, 86 (1993), pp. 245-247
[50.]
G. Ginter, H.P. Soyer, E. Rieger.
Vaginal yeast colonization and promiscuity. A study of 197 prostitutes.
Mycoses, 35 (1992), pp. 177-180
[51.]
A. Bazarra Fernández, A. Castro Iglesias.
Vaginosis bacteriana ¿dónde nos encontramos?.
Med Clin (Barc), 110 (1998), pp. 213-214
[52.]
B. Martínez de Tejada, O. Coll, M. De Flores, S.L. Millier, D.V. Landers.
Prevalencia de vaginosis bacteriana en una población obstétrica de Barcelona.
Med Clin (Barc), 110 (1998), pp. 201-204
[53.]
P.J. Meis, R.L. Goldenberg, B. Mercer, A. Moaward, A. Das, D. McNellis, et al.
The pretern prediction study: significance of vaginal infections.
Am J Obstet Gynecol, 173 (1995), pp. 1.231-1.235
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
